Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
Tufts Study Finds mAbs Development On The Rise

March 11, 2008
According to Tufts Center for the Study of Drug Development (Tufts CSDD) the number of monoclonal antibody products in development nearly tripled in the last decade. A recent Tufts CSDD study found that monoclonal antibody products, referred to as mA…  Read More »
Eusa Pharma to Acquire Cytogen

March 11, 2008
Eusa Pharma, Inc. has entered into a definitive agreement to acquire all the outstanding shares of Cytogen Corp. for $22.6 million cash. Cytogen has three oncology and pain control products on the U.S. market, a specialized oncology sales force, and…  Read More »
Xoma Ltd.

March 11, 2008
Mary L. Anderson has been appointed vice president of business development, Xoma Ltd. Ms. Anderson will oversee Xoma's licensing activities related to the company's therapeutic pipeline, support the antibody collaborations business and the licensing…  Read More »
Lilly Ends Insulin Program

March 10, 2008
Eli Lilly and Co. terminated its AIR Insulin development program with partner Alkermes, Inc. The program has been in Phase III development as a potential treatment for type 1 and type 2 diabetes. According to the company, the decision is not related…  Read More »
Abbott Enters Pact To Develop Lung Cancer Test

March 10, 2008
Abbott's molecular diagnostics business has entered into an agreement with Genentech, Inc., F. Hoffmann-La Roche and OSI Pharmaceuticals, Inc. to develop a gene test to assess the clinical benefit of Tarceva, an oral tablet indicated for the treatmen…  Read More »
Patheon 1Q08

March 7, 2008
Patheon 1Q08 1Q Revenues: $164 million (+11%) 1Q Loss: $15 million (net loss of $2 million in 1Q07) Comments: Revenues from European operations grew 35% to $20 million, but weakness of the U.S. dollar added $6.9 million to that result. On a…  Read More »
Hovione Acquires Hisyn Facility in China

March 7, 2008
Hovione has purchased 75% of Hisyn Pharmaceutical Co. Ltd. The acquisition "provides Hovione with significant drug substance manufacturing production capacity and strengthens its 20-year presence in China," according to a company statement.…  Read More »
Gilead Submits MAA for CF Infections

March 7, 2008
Gilead Sciences has submitted a Marketing Authorisation Application (MAA) for aztreonam lysine 75 mg powder for nebuliser solution (aztreonam lysine) in the EU. Aztreonam lysine is an investigational therapy in development for people with cystic fibr…  Read More »
Amgen To License MAb from Kyowa Hakko

March 6, 2008
Amgen has entered an exclusive licensing agreement to develop and commercialize Kyowa Hakko Kogyo Co.'s humanized monoclonal antibody KW-0761 worldwide, except in Japan, Korea, China and Taiwan, where Kyowa Hakko will retain development and commercia…  Read More »
Evotec, InterMune Expand Research Pact

March 6, 2008
InterMune, Inc. has signed its second drug discovery contract with Evotec AG under which Evotec will support InterMune's research efforts with its medicinal chemistry expertise. Evotec will use its technologies in computational chemistry, protein pro…  Read More »
Morphotek Licenses Anti-Cancer Antibody

March 6, 2008
Morphotek, Inc., a subsidiary of Eisai Co., Ltd., has signed a licensing agreement with Human Monoclonals International, Inc. (HMI) for exclusive rights to a human monoclonal IgM antibody that is specific to a cancer cell surface antigen. Morphotek w…  Read More »
Pfizer Presents New Growth Strategy

March 5, 2008
At a meeting for investment analysts, Pfizer presented strategies to accelerate and refocus its pipeline and exploit new opportunities for global growth. “We have made real changes in how we operate our business — in our structure, cultur…  Read More »
Bristol-Myers Squibb

March 5, 2008
Jean-Marc Huet has been named senior vice president and chief financial officer, Bristol-Myers Squibb, effective March 31, 2008. Mr. Huet will be responsible for directing and managing the company's fiscal operations, as well as the global financial…  Read More »
Azopharma Acquires Analytical Development Corp.

March 5, 2008
Azopharma Product Development Group, Inc. has acquired Analytical Development Corporation (ADC), a bioanalytical lab located in Colorado Springs, CO. ADC, founded in 1971 as a CRO providing bioanalytical services to the pharmaceutical and biotechnolo…  Read More »
Pfizer

March 4, 2008
William Ringo has been named senior vice president of strategy and business development, Pfizer. He will be responsible for guiding the company's overall strategic planning and business development activities, reporting to chairman and chief executiv…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: